Navigation Links
AGA supports new guidelines favoring tests that prevent colorectal cancer

Bethesda, MD (March 5, 2008) New consensus colorectal cancer guidelines released today state for the first time that the primary goal of colorectal cancer screening is cancer prevention. Previous guidelines have given equal weight to tests for detecting cancer and preventing cancer. By removing polyps from the large bowel, colonoscopy is the only screening test that also prevents colorectal cancer.

Colorectal cancer prevention should be the primary goal of screening, said Nicholas LaRusso, MD, AGAF, president, American Gastroenterological Association (AGA) Institute. Detection and removal of precancerous lesions is essential to improve the health of Americans.

The guidelines, which represent the most current scientific evidence and expert opinion available, are a joint effort of the American Cancer Society, the American College of Radiology and the U.S. Multi-society Task Force (comprised of the American College of Gastroenterology, the American Gastroenterological Association (AGA) Institute and the American Society for Gastrointestinal Endoscopy).

While the AGA Institute considers optical colonoscopy the definitive screening and treatment procedure for colorectal cancer, we support all clinically proven options for colorectal cancer screening. There are many tests available for screening and everyone age 50+ should talk with their physician about what test is available to them, said John I. Allen, MD, MBA, AGAF chair of the AGA Institute Clinical Practice and Quality Management Committee.

The panel of experts representing the societies listed above added two new tests as options: stool DNA (sDNA) and CT colonography (CTC). The AGA Institute supports CTC as a promising screening test for colorectal cancer, which we believe will be in widespread clinical use in the near future.

The expert panel also concluded that any proposed colorectal screening test that has not been shown in the medical literature to detect the majority of cancers present at the time of testing should not be offered to patients for colorectal cancer screening, including some types of previously endorsed guiaic-based stool tests.

Based on a review of the historic and recent evidence, the following tests were deemed acceptable options for the early detection of colorectal cancer and adenomatous polyps for asymptomatic adults aged 50 years and older:

Tests That Detect Adenomatous Polyps and Cancer

  • Flexible sigmoidoscopy every 5 years, or
  • Colonoscopy every 10 years, or
  • Double contrast barium enema (DCBE) every 5 years, or
  • CT colonography (CTC) every 5 years

Tests That Primarily Detect Cancer

  • Annual guaiac-based fecal occult blood test (gFOBT) with high test sensitivity for cancer, or
  • Annual fecal immunochemical test (FIT) with high test sensitivity for cancer, or
  • Stool DNA test (sDNA), with high sensitivity for cancer, interval uncertain.

The guidelines will appear in the May issue Gastroenterology, May/June issue of CA: A Cancer Journal for Clinicians, and are published early online on CA First Look.


Contact: Aimee Frank
American Gastroenterological Association

Related medicine news :

1. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
2. Encision Supports National Patient Safety Awareness Week
3. Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants
4. AdvaMed Supports Key Changes to Disclosure Legislation
5. Michael Aram Supports The NAZ Foundation
6. Cogon Systems, Inc. Supports the Formation of Virtual Health Communities with its Community MOMENT OF CARE(R)
7. Evolutionary history of SARS supports bats as virus source
8. Seven Out of 10 Americans Would Vote for a Presidential Candidate Who Supports a Nationwide Health Information Network, CSC Survey Says
9. AT&T Tennessee Supports Local Disaster Relief Efforts
10. AIDS Action Committee Offers and Supports Variety of Events to Honor National Black HIV/AIDS Awareness Day
11. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
(Date:11/30/2015)... NC (PRWEB) , ... November 30, 2015 , ... ... Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various categories ... These four influential figures make up an elite group of Gold Medal Moms ...
(Date:11/30/2015)... Islands, BWI (PRWEB) , ... December 01, 2015 , ... ... Recently Caribbean Journal, one of the leading digital news sites highlighting Caribbean destinations, has ... The weather. While much of North America shivers under chilly grey skies or ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
Breaking Medicine Technology: